300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Switzerland (September 2026)

The most active venture capital funds and angel investors investing in Switzerland Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Foundation for Innovation and Technology (FIT)
VC Fund
46 Switzerland, France, United States Debt Financing, Grant, Seed Health Care, Biotechnology, Artificial Intelligence $20k–$2.5M
Zürcher Kantonal Bank
VC Fund
38 Switzerland, Germany, Japan Seed, Series A, Series B Health Care, Biotechnology, Medical Device $1M–$20M
Verve Ventures
VC Fund
20 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $1.2M–$45M
BioMedPartners
VC Fund
19 Switzerland, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $5.3M–$75M
M Ventures
VC Fund
16 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
VI Partners
VC Fund
14 Switzerland, Germany, United States Series A, Series B, Series C Health Care, Biotechnology, Software $3.2M–$100M
Bernina BioInvest
VC Fund
13 Switzerland Seed, Series A, Series B Biotechnology, Health Care, Medical $1.5M–$65M
Versant Ventures
VC Fund
13 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $5M–$108M
HTGF (High-Tech Gruenderfonds)
VC Fund
12 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $850k–$31M
EQT Life Sciences
VC Fund
12 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
Novartis Venture Fund
VC Fund
11 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Eclosion SA
VC Fund
11 Switzerland Seed, Series C Biotechnology, Pharmaceutical, Health Care $1.6M–$28M
Sofinnova Partners
VC Fund
10 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Schroder Adveq
VC Fund
10 Switzerland, United States, India Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $5M–$100M
Kickfund
VC Fund
9 Switzerland, France, Germany Seed, Pre-Seed, Convertible Note Health Care, Biotechnology, Manufacturing $110k–$5.7M
redalpine
VC Fund
9 Germany, Switzerland, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Software $1.6M–$125M
Kinled Holding
VC Fund
9 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $594k–$40M
SICTIC
VC Fund
9 Switzerland, Germany, Tanzania Seed, Pre-Seed Software, Artificial Intelligence, Information Technology $264k–$3.7M
GoBeyond
VC Fund
8 Switzerland, Germany, United Kingdom Seed, Series A Software, Health Care, Information Technology $495k–$5M
Lichtsteiner Foundation
VC Fund
8 Switzerland Seed, Series A Biotechnology, Health Care, Medical $1.6M–$6.8M
4FOX Ventures
VC Fund
7 Switzerland, United States Series A, Seed, Series B Medical Device, Medical, Health Care $1.8M–$69M
Boehringer Ingelheim Venture Fund
VC Fund
7 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Novo Holdings
VC Fund
7 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Index Ventures
VC Fund
7 United States, United Kingdom, France Series A, Series B, Seed Software, E-Commerce, Internet $1.5M–$100M
Omega Funds
VC Fund
6 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Swisscom Ventures
VC Fund
6 Switzerland, United States, United Kingdom Series B, Series A, Series C Software, SaaS, Information Technology $2M–$80M
Aglaia BioMedical Ventures
VC Fund
5 The Netherlands, United States, Switzerland Series A, Series B, Seed Biotechnology, Therapeutics, Pharmaceutical $5.5M–$23M
Aargauische Kantonalbank
VC Fund
5 Switzerland Series B, Seed, Series A Medical Device, Dental, Medical $1.4M–$3.6M
Broadview Ventures
VC Fund
5 United States, Switzerland, Canada Series A, Seed, Series B Health Care, Biotechnology, Medical Device $1M–$45M
Founderful
VC Fund
5 Switzerland, United Kingdom, Canada Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $810k–$24M
Pfizer Venture Investments
VC Fund
5 United States, United Kingdom, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$120M
Privilège Ventures
VC Fund
5 Switzerland, Italy, France Seed, Pre-Seed, Series A Health Care, Software, Wearables $667k–$7M
Pureos Bioventures
VC Fund
5 France, Switzerland, United States Series A, Series B, Series C Biotechnology, Therapeutics, Medical $7.1M–$125M
Penny Schiffer
Angel
4 Switzerland, Germany, United Kingdom Seed, Series A, Series B Medical, Software, Health Care $495k–$8M
Lakestar
VC Fund
4 Germany, United States, United Kingdom Seed, Series A, Series B Software, Artificial Intelligence, FinTech $2.2M–$91M
b2venture
VC Fund
4 Germany, Switzerland, United Kingdom Series A, Seed, Series B Software, Health Care, Information Technology $1.4M–$52M
OrbiMed
VC Fund
4 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $9.8M–$160M
Fongit Seed Invest
VC Fund
4 Switzerland Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$3.3M
Gilde Healthcare
VC Fund
4 United States, The Netherlands, Germany Series B, Series C, Series A Health Care, Biotechnology, Medical $9.5M–$135M
Endeavour Vision
VC Fund
4 United States, Switzerland, France Series C, Series B, Series A Health Care, Medical, Biotechnology $2.1M–$115M
Inkef
VC Fund
4 The Netherlands, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Medical $3.1M–$86M
Neomed Management
VC Fund
4 Switzerland, United States, Italy Series B, Series C, Series A Health Care, Biotechnology, Medical $8.3M–$44M
New Enterprise Associates
VC Fund
4 United States, India, United Kingdom Series A, Series B, Series C Software, Health Care, Biotechnology $6M–$103M
Aravis Ventures
VC Fund
4 Switzerland, United States, Denmark Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $4.4M–$80M
Polytech Ventures
VC Fund
4 Switzerland, United States, Spain Seed, Series A, Series B Software, Financial Services, FinTech $500k–$10M
JFG Life Sciences Foundation
VC Fund
3 Switzerland Seed, Pre-Seed Biotechnology, Medical, Biopharma $5.2M–$13M
Kurma Partners
VC Fund
3 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.3M–$95M
Forty51 Ventures
VC Fund
3 Switzerland Seed, Series A Therapeutics, Medical, Health Care $3.5M–$3.5M
Swisscanto Private Equity
VC Fund
3 Switzerland, Denmark, Germany Series B, Series C, Venture - Series Unknown Health Care, Biotechnology, Manufacturing $9.2M–$54M
EVA Basel
VC Fund
3 Switzerland Seed, Series A Biotechnology, Medical Device, Medical $1.9M–$3.6M
Access all 898 investors in Switzerland Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Foundation for Innovation and Technology (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 46 investments in Switzerland Biotech startups, 31 in the past 12 months

The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France, United States

Investor stats

  • Total investments: 257
  • Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $99k–$530k
  • Lead/follow: 93% lead, 7% follow

Portfolio highlights

  • SixtineAI — is an AI-driven clinical documentation and workflow assistant specifically designed for healthcare providers.
  • Nextrainers — Nextrainers is a sports technology company that provides AI-powered football training sessions, tactical analysis, and player progression.
  • Documenter AI — Complete AI copilot platform for enterprise project management, compliance automation, and business process automation. Deploy intelligent agents, automate workflows, and ensure compliance across all industries.
Show all investments...

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 38 investments in Switzerland Biotech startups

Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, Japan

Investor stats

  • Total investments: 205
  • Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.9M–$20M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $150M in 2024

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 20 investments in Switzerland Biotech startups, 11 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 301
  • Round size: Seed $1.2M–$11M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
  • Atana Elements — Atana is accelerating the exploration and development of flowing critical minerals and industrial gases. Atana uses a proprietary tech stack to identify and mature mineral resources quickly and effectively.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland · 19 investments in Switzerland Biotech startups

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 88
  • Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $106M in 2018

Portfolio highlights

  • T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 16 investments in Switzerland Biotech startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 187
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

VI Partners
VC Fund · Altendorf, Schwyz, Switzerland · 14 investments in Switzerland Biotech startups

Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, United States

Investor stats

  • Total investments: 113
  • Round size: Series A $3.2M–$23M; Series B $3.3M–$41M; Series C $7M–$100M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $110M in 2020

Portfolio highlights

  • Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
  • Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
  • Sonic Emotion — Sonic Emotion Absolute 3DTM sound technology provides an innovative unique solution for an immersive natural 3D sound reproduction by implementing audio products with sound field control from only 2, 3, 4 or 6+ channels using a single compact device (and an optional subwoofer internal or external).
Show all investments...

Bernina BioInvest
VC Fund · Zug, Zug, Switzerland · 13 investments in Switzerland Biotech startups

Bernina BioInvest is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.5M–$20M; Series A $15M–$65M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 13 investments in Switzerland Biotech startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 324
  • Round size: Series A $5M–$78M; Series B $12M–$105M; Series C $12M–$108M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $5M in 2024

Portfolio highlights

  • Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
  • Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 12 investments in Switzerland Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 739
  • Round size: Seed $850k–$7M; Series A $3.1M–$31M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 12 investments in Switzerland Biotech startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $282M in 2023

Portfolio highlights

  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
  • Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 11 investments in Switzerland Biotech startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 230
  • Round size: Series A $5.1M–$85M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Eclosion SA
VC Fund · Geneva, Geneve, Switzerland · 11 investments in Switzerland Biotech startups

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series C
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
  • Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
  • MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 10 investments in Switzerland Biotech startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 350
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Schroder Adveq
VC Fund · Zürich, Zurich, Switzerland · 10 investments in Switzerland Biotech startups

Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: Switzerland, United States, India

Investor stats

  • Total investments: 36
  • Round size: Series A $5M–$22M; Series B $11M–$73M; Series C $15M–$100M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — raised $113M in 2020

Portfolio highlights

  • Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
  • Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able to do in India yet.The website has over 500 designs ofeye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery.Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision to name a few) and be it disposable, toric, colored, or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Show all investments...

Kickfund
VC Fund · Basel, Basel-Stadt, Switzerland · 9 investments in Switzerland Biotech startups, 15 in the past 12 months

Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Switzerland, France, Germany

Investor stats

  • Total investments: 50
  • Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4M; Convertible Note $110k–$118k
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $80M in 2023

Portfolio highlights

  • Bewelab SA — Bewe is a mobile game designed to reduce cravings, using neuroscience to automatically retrain your brain and effortlessly reclaim your health.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Show all investments...

redalpine
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Biotech startups, 19 in the past 12 months

redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: Germany, Switzerland, United Kingdom

Investor stats

  • Total investments: 201
  • Round size: Seed $1.6M–$13M; Series A $3.2M–$33M; Series B $16M–$125M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $200M in 2024

Portfolio highlights

  • microagi — Accelerating embodied AGI
  • telli — A world where every interaction is worth having. https://t.co/Qa65ENaxKL
  • Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 9 investments in Switzerland Biotech startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 143
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Show all investments...

SICTIC
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Biotech startups

SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, Germany, Tanzania

Investor stats

  • Total investments: 299
  • Round size: Seed $504k–$3.7M; Pre-Seed $264k–$2.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
  • Ionic Wind Technologies — Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
Show all investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland · 8 investments in Switzerland Biotech startups

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 190
  • Round size: Seed $495k–$5M; Series A $1.2M–$4.5M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Stylect — Stylect is a mobile app to to help women discover their perfect shoe. They aggregate products from multiple websites and based on users' preferences (that they gather through a hot-or-not interface), they recommend better products. Their users are able to keep track of and buy the products they like and receive notifications whenever a productthey love goes on sale. Finally, They use geolocation to let their users know when a shoe is selling in a store nearby.
  • LockStyler — LockStyler is a hair locks coloring device used by hairdressers for hair highlighting and lowlighting. It is composed of an applicator, cartridge, and base. LockStyler was launched in 2014 and is manufactured in Montreux, Switzerland.
  • Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Show all investments...

Lichtsteiner Foundation
VC Fund · Berne, Bern, Switzerland · 8 investments in Switzerland Biotech startups

Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $1.6M–$6.8M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Hemostod — Developing universal platelets and next-generation diagnostics
  • DigeHealth — DigeHealth combines a wearable acoustic sensor with your sleep, stress and nutrition data to reveal how your lifestyle affects your digestive health.
  • Allegria Therapeutics — Allegria Therapeutics is a Swiss biotech company targeting mast cells to redefine the treatment of allergic and inflammatory diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
4FOX Ventures
VC Fund · Luxembourg, Luxembourg, Luxembourg · 7 investments in Switzerland Biotech startups

4FO Ventures

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $1.8M–$3.3M; Series A $1.8M–$11M; Series B $5.5M–$69M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
  • Neo Medical — Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 7 investments in Switzerland Biotech startups, 7 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 7 investments in Switzerland Biotech startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 398
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

Index Ventures
VC Fund · San Francisco, California, United States · 7 investments in Switzerland Biotech startups

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 1537
  • Round size: Seed $1.5M–$15M; Series A $5M–$35M; Series B $12M–$100M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely actively investing — fresh fund, raised $400M in 2026

Portfolio highlights

  • Apron — You run payments. Not the other way round.
  • Gluster — Gluster is an open source, distributed file system that is capable of scaling to several petabytes and handling many clients. In order to simplify the task of storing and managing the growth of unstructured data, Gluster has created and delivered open source scale-out cloud storage software. It allows enterprises to combine large numbers ofcommodity storage and compute resources into a high performance, virtualized, and centrally managed pool. Gluster has been deployed by hundreds of global enterprises and service providers across industries including media, healthcare, consumer internet, energy, and biotech. It is based on a stackable user space design and can deliver high performance for diverse workloads. It has many attributes that includes: Scalability and Performance, Global Namespace, Elastic Hash Algorithm, Elastic Volume Manager, and Standards-based. Gluster is privately-held and headquartered in Sunnyvale, California.
  • StorSimple — Learn how to migrate a StorSimple 8100 or 8600 appliance to Azure File Sync.
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 6 investments in Switzerland Biotech startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 170
  • Round size: Series A $16M–$200M; Series B $38M–$165M; Series C $14M–$208M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $470M in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
Show all investments...

Swisscom Ventures
VC Fund · Zürich, Zurich, Switzerland · 6 investments in Switzerland Biotech startups, 6 in the past 12 months

Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 156
  • Round size: Series A $2M–$22M; Series B $2M–$60M; Series C $8.6M–$80M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
  • CDDS — CDDS is a defense technology firm producing AI-powered autonomous interceptor drones for countering unmanned aerial systems.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
Show all investments...

Aglaia BioMedical Ventures
VC Fund · Bilthoven, Utrecht, The Netherlands · 5 investments in Switzerland Biotech startups

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since thenumber of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into novel products is a prerequisite for success. Aglaia's focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development.Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Pharmaceutical
  • Stage:Series A, Series B, Seed
  • Geography: The Netherlands, United States, Switzerland

Investor stats

  • Total investments: 13
  • Round size: Series A $5.5M–$17M; Series B $21M–$23M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $65M in 2014

Portfolio highlights

  • Inthera Bioscience — Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
  • InteRNA Technologies — A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation drug delivery
  • Sapreme Technologies — Enabling endosomal escape
Show all investments...

Aargauische Kantonalbank
VC Fund · Aarau, Aargau, Switzerland · 5 investments in Switzerland Biotech startups

Aargauische Kantonalbank (AKB) is a classical universal bank for private and corporate clients and institutional investors. They offer comprehensive services in all areas of banking. Their strengths include the needs-based, personalized and comprehensive advice and a comprehensive and competent care. The AKB has 31 offices in the canton of Aargauand the adjacent area Solothurn Olten-Gösgen-Gäu. Their company has about 790 employees and about 79 students. They serve approximately 230,000 customers. The AKB has been awarded by the rating agency Standard & Poor's AA + rating.

Show more...

Investment focus

  • Industry: Medical Device, Dental, Medical
  • Stage:Series B, Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 13
  • Round size: Seed $1.5M–$3.6M; Series B $1.4M–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aliunid — Aliunid is a cleantech startup that records, optimizes, and controls energy flows using real-time data.
  • Mesh — MESH is automating rebar fabrication and construction processes using robotics and software. Our mission is to bring modern robotics to rebar industry.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 5 investments in Switzerland Biotech startups

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 83
  • Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Show all investments...

Founderful
VC Fund · Zürich, Zurich, Switzerland · 5 investments in Switzerland Biotech startups, 15 in the past 12 months

Founderful operates as a venture capital firm and a Switzerland’s leading pre-seed fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, United Kingdom, Canada

Investor stats

  • Total investments: 111
  • Round size: Seed $1.5M–$14M; Pre-Seed $810k–$4.3M; Series A $3M–$24M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — raised $143M in 2024

Portfolio highlights

  • Fusionality — Fusionality is a Swiss fusion-technology company focused on measurement, control, and data systems for fusion devices.They combine expertise in fusion physics, control engineering, AI/ML, simulation, diagnostics, and real-time software.Their goal is to help fusion companies and research labs operate devices more efficiently and accelerate thedevelopment of commercial fusion energy.
  • Stellar Alpina — Stellar Alpina develops modular lunar landers and the RDRE propulsion modules that power them, combining rapid hardware iteration with a scalable platform approach for reliable missions from Earth orbit to the Moon.
  • Exclaim Robotics — Autonomous mobile robots for the AI data center.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pfizer Venture Investments
VC Fund · New York, New York, United States · 5 investments in Switzerland Biotech startups

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 188
  • Round size: Series A $10M–$100M; Series B $20M–$120M; Series C $15M–$102M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $600M in 2018

Portfolio highlights

  • Flare Therapeutics — Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets fortranscription factor regulation to address mutations that cause disease. Its drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
  • Flexion Therapeutics — Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

Privilège Ventures
VC Fund · Zürich, Zurich, Switzerland · 5 investments in Switzerland Biotech startups

Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team

Show more...

Investment focus

  • Industry: Health Care, Software, Wearables
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland, Italy, France

Investor stats

  • Total investments: 24
  • Round size: Seed $1M–$5.9M; Pre-Seed $667k–$1.6M; Series A $4.1M–$7M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $21M in 2022

Portfolio highlights

  • Xsensio — Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
  • ENANTIOS — ENANTIOS specializes in creating benchtop analytical instruments that provide industries, research institutions, and academic facilities.
  • Develop Players — Supporto clinico per ADHD e DSA online. Aiutiamo adulti, bambini e ragazzi con screening, potenziamento e percorsi psicologici personalizzati.
Show all investments...

Pureos Bioventures
VC Fund · Küsnacht, Zurich, Switzerland · 5 investments in Switzerland Biotech startups

Venture capital for companies developing innovative therapeutics.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 36
  • Round size: Series A $12M–$123M; Series B $7.1M–$100M; Series C $22M–$125M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $205M in 2020

Portfolio highlights

  • NovaGo Therapeutics — NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic propertiesgenerated through their Reverse Translational Medicine™ (RTM™) technology platform.
  • Tavo Biotherapeutics — Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
  • PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Show all investments...

Penny Schiffer
Angel · 4 investments in Switzerland Biotech startups

Penny Schiffer - CEO & Co-founder @ Raized.ai

Show more...

Investment focus

  • Industry: Medical, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 34
  • Round size: Seed $495k–$8M; Series A $1.2M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
  • Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Show all investments...

Lakestar
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Biotech startups

Lakestar invests in founders and technologies shaping Europe's future, helping build resilience, sovereignty, and long-term growth in a changing world.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 247
  • Round size: Seed $2.2M–$19M; Series A $6.7M–$65M; Series B $16M–$91M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $300M in 2026

Portfolio highlights

  • Swan — Use Swan's APIs to embed white-labeled banking features like accounts, cards, and IBANs into your workflows and UX.
  • Vertice — The SaaS purchasing platform that gives finance leaders cost control, efficiency and flexibility.
  • Cambridge Aerospace — Our mission is to eliminate the risk of existential war in Europe.
Show all investments...

b2venture
VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 4 investments in Switzerland Biotech startups

B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Switzerland, United Kingdom

Investor stats

  • Total investments: 272
  • Round size: Seed $1.4M–$8.8M; Series A $3.4M–$23M; Series B $6.9M–$52M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fresh fund, raised $179M in 2026

Portfolio highlights

  • Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
  • Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
  • Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 4 investments in Switzerland Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 740
  • Round size: Series A $9.8M–$140M; Series B $24M–$148M; Series C $19M–$160M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
  • Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
  • Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Show all investments...

Fongit Seed Invest
VC Fund · Plan-les-ouates, Geneve, Switzerland · 4 investments in Switzerland Biotech startups

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$1.4M; Series A $2.3M–$3.3M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands · 4 investments in Switzerland Biotech startups, 6 in the past 12 months

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, The Netherlands, Germany

Investor stats

  • Total investments: 131
  • Round size: Series A $9.5M–$62M; Series B $14M–$135M; Series C $21M–$80M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $296M in 2026

Portfolio highlights

  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
  • GT Medical Technologies — GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors.
  • Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Show all investments...

Endeavour Vision
VC Fund · Geneva, Geneve, Switzerland · 4 investments in Switzerland Biotech startups

Endeavour Vision is an investment advisory firm focused on transformative healthcare technologies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series C, Series B, Series A
  • Geography: United States, Switzerland, France

Investor stats

  • Total investments: 76
  • Round size: Series A $2.1M–$30M; Series B $7M–$48M; Series C $12M–$115M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $375M in 2021

Portfolio highlights

  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
  • Venture Med Group — Create a dynamic website for your electrical services with Avada & WordPress. Showcase your expertise, services, and attract clients with engaging designs.
  • Kestra Medical Technologies, Inc. — Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Inkef
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Biotech startups

SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: The Netherlands, United States, Germany

Investor stats

  • Total investments: 92
  • Round size: Seed $3.1M–$24M; Series A $3.4M–$42M; Series B $8.2M–$86M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $562M in 2016

Portfolio highlights

  • Silverflow — Silverflow offers global payment technology to power financial institutions.
  • Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
  • Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Show all investments...

Neomed Management
VC Fund · Oslo, Oslo, Norway · 4 investments in Switzerland Biotech startups

NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Series A
  • Geography: Switzerland, United States, Italy

Investor stats

  • Total investments: 43
  • Round size: Series A $8.3M–$37M; Series B $20M–$42M; Series C $9.2M–$44M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $51M in 2015

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
  • JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Show all investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 4 investments in Switzerland Biotech startups

Foundational partners to ambitious founders at every stage of company-building.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1995
  • Round size: Series A $6M–$55M; Series B $10M–$90M; Series C $15M–$103M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $468M in 2024

Portfolio highlights

  • Zyngenia
  • Radiology Partners — Radiology Partners is the leading radiology practice in the U.S., consisting of a network of of radiology practices serving hospitals and other healthcare facilities across the nation.
  • Sportsrocket — Sportsrocket is a New York-based company working to give sports fans access to live games and events, highlights, and shows. The company works with leading leagues, publishers, and rights-holders, including Major League Soccer, the PGA Tour, Scout Media, and AS Roma, to create and power customized OTT platforms. Incubated by Bedrocket MediaVentures, Sportsrocket's innovative approach is based on a proprietary sports media operating system, that offers an integrated solution for the production, distribution, management, and monetization of sports media across all platforms.
Show all investments...

Aravis Ventures
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Biotech startups

Aravis is the first independent Swiss on-shore private equity house, an established investor in the renewable energy and life science spaces. We are a "hands-on" investor taking leading positions and understanding the balance between finance, commercial assets and people. With this distinct and crafted approach, we are serving over 30leading investors including corporates, pension funds, government funds, insurance companies and family offices. Currently actively managing more than a quarter of a billion Swiss francs, we have a cumulative history of investments in over 100 companies. These have resulted in several noticeable exits including the divestment of several renewable energy companies and a number of life science reverse take-overs, listings and trade sales. Our many years of experience in the Swiss fund industry have enabled us to establish a platform with a comprehensive offering of investment, accounting, regulatory and reporting expertise. Located in Zurich, Aravis was founded in 2001.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, United States, Denmark

Investor stats

  • Total investments: 19
  • Round size: Series A $4.4M–$80M; Series B $6.8M–$33M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Bird Rock Bio — We are a biopharmaceutical company focused on the development of proprietary cannabinoid derivatives for the treatment of glaucoma and other diseases with significant unmet medical needs. Our innovative approach to drug development combines strong science with the drive to find solutions where the need is the greatest.
  • Synaffix BV — Synaffix BV is a clinical-stage, Netherlands-based biotech company that has established a proprietary antibody-drug conjugate (ADC) technology platform that enhances efficacy and tolerability compared to all 3 major clinical-stage ADC technologies. We have a 'one-stop' technology offering (including 4 different ADC payloads) thatenables the development of proprietary ADCs from any antibody and our patent portfolio provides patent protection of resulting Products through at least 2035.Our business model is technology out-licensing and we regularly engage in research collaborations with other companies that are interested in developing highly competitive ADC products for their own pipelines.Disclosed partnerships to date include those with ADC Therapeutics and Mersana Therapeutics
  • Hedera-22 — Explore the top online casino no verification withdrawal Australia sites. Fast payouts, crypto banking, and safe pokies at trusted no KYC casinos.
Show all investments...

Polytech Ventures
VC Fund · Lausanne, Vaud, Switzerland · 4 investments in Switzerland Biotech startups

Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, United States, Spain

Investor stats

  • Total investments: 53
  • Round size: Seed $500k–$3.5M; Series A $2.1M–$10M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
  • Hemostod — Developing universal platelets and next-generation diagnostics
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Show all investments...

JFG Life Sciences Foundation
VC Fund · 3 investments in Switzerland Biotech startups

JFG Life Sciences Foundation is a non-profit foundation.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $5.2M–$13M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
  • Invasight — Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
  • NXI Therapeutics — NXI Therapeutics - Creating Tomorrow's Immunotherapies | The beginning of a new era of specificity and safety in the immunosuppressive therapy market
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in Switzerland Biotech startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 138
  • Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

Forty51 Ventures
VC Fund · 3 investments in Switzerland Biotech startups

Discover the unmet need of patients with uveitic glaucoma, an end-stage disease comprised of two serious eye conditions: non infectious uveitis and glaucoma. %

Show more...

Investment focus

  • Industry: Therapeutics, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 6
  • Round size: Seed $3.5M–$3.5M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Ferrosa Therapeutics — Ferrosa Therapeutics is a Basel, Switzerland-based biotechnology company developing a first-in-class bispecific antibody to treat anemia of inflammation.
  • Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
  • Allegria Therapeutics — Allegria Therapeutics operates as a biotech company.
Show all investments...

Swisscanto Private Equity
VC Fund · Zürich, Zurich, Switzerland · 3 investments in Switzerland Biotech startups

We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series B, Series C, Venture - Series Unknown
  • Geography: Switzerland, Denmark, Germany

Investor stats

  • Total investments: 35
  • Round size: Series B $9.2M–$52M; Series C $22M–$54M; Venture - Series Unknown $20M–$47M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $204M in 2018

Portfolio highlights

  • MedTrace Pharma — MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly.
  • ANYbotics — ANYbotics provides autonomous legged robots for industrial applications to provide high availability and reliability in automated routine inspections.
  • Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
Show all investments...

EVA Basel
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Switzerland Biotech startups

EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 4
  • Round size: Seed $1.9M–$3.6M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AOT - Advanced Osteotomy Tools — AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser,robotics and navigation systems to re-invent bone surgery (osteotomy).
  • POLYNEURON — Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patientswith immune disorders in a safe and effective manner.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Show all investments...

Biotech Investor funding in Switzerland at a glance

Stats across 1.2k deals from 898 investors.

898
investors
in Switzerland Biotech startups
1.2k
deals
in Switzerland Biotech startups
$1.7M
median round
in Switzerland Biotech startups
46%
lead investors
lead at least one round
32%
Grant
most common funding stage
91/9
VC / Angel
share of investor count

Access all 898 investors in Switzerland Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 898 investors investing in Switzerland Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists